Cecilie Delphin Amdal

Author information from the last article

Seksjon for hode-hals-onkologi

Avdeling for kreftbehandling

Oslo universitetssykehus

Cecilie Delphin Amdal er ph.d., spesialist i onkologi og forskningsgruppeleder for hud- og hode-hals-kreft.

Articles by Cecilie Delphin Amdal

Are surrogate endpoints useful in clinical studies?

Cecilie Delphin Amdal,
Kristin Bjordal

17.06.2014: Surrogate endpoints are often used as measures of therapeutic effect in clinical studies, for example, blood pressure as a risk indicator for cardiovascular disease. Sometimes the presumed association is uncertain. What do we need to be aware of when we interpret the results of such studies, and...